A new study snapshot and updated ethics and regulatory documentation are now available for the iPATH trial. Eighteen months into the study, the research team reviewed and updated the minutes of their initial consultation with the Ethics and Regulatory Core.
New resources for iPATH include:
iPATH, an NIH Collaboratory Trial led by principal investigator Sara Singer of Stanford University, is a stepped-wedge, cluster randomized, hybrid effectiveness-implementation trial of a practice transformation strategy for type 2 diabetes in federally qualified health centers in California, Massachusetts, Ohio, and Puerto Rico. The study will evaluate the impact of the practice transformation strategy and identify process elements that influence implementation effectiveness.
iPATH is supported within the NIH Pragmatic Trials Collaboratory by the National Institute on Minority Health and Health Disparities. Learn more about iPATH.